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rofacial Pain is the field of dentistry devoted to the diagnosis and management of chronic, complex, facial pain
and oromotor disorders. This specialty in dentistry has developed over a number of years out of the need for
better understanding of a group of patients who somehow were not clearly suffering from dental pain disorders, but
still did not seem to have a clearly defined medical problem. After a long period of treating patients based on the
mechanicist aspect of the disease, our profession has realized the importance of basic knowledge and differencial
diagnosis in order to proper manage these patients. This modification in the approach has caused severe changes in
education as well as in clinical activities. Historically considered as a problem of occlusion, Orofacial Pain, including
Temporomandibular Disorders (TMD) has recently reached the status of “Specialty” in Brazil. Therefore, this
paper aims to discuss the main differences between musculoskeletal and neuropathic pain and the importance of
basic knowledge to perform successful management.
UNITERMS:  Orofacial pain; Neuropathic pain; Pain transmission.
INTRODUCTION
Orofacial pain is the field of dentistry devoted to
the diagnosis and management of chronic, complex,
facial pain and oromotor disorders1,13  This specialty
in dentistry has developed over a number of years out
of the need for better understanding of a group of
patients who somehow were not clearly suffering from
dental pain disorders, but still did not seem to have a
clearly defined medical problem1.
Orofacial pain, like pain elsewhere in the body, is
usually the result of tissue damage and the activation
of nociceptors, which transmit a noxious stimulus to
the brain18. However, due to the rich innervation of
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the head, face and oral structures, orofacial pain
entities are often very complex and can be difficult to
diagnose.
Considered in the past as a “problem of occlusion”,
most of orofacial pain management strategies were
based only on anecdotal reports. Indeed, the traditional
mechanicist view of the problem has lead to extensive
occlusal reconstruction treatments, with no significant
results on pain. Most of recent papers has demonstrated
a non-association between occlusion and orofacial
pain, including Temporomandibular Disorders 5. Dr.
Wedden Bell has provided an enormous contribution
for the fiel of Orofacial Pain. Bell gave us a road map
where he defined the sources of pain as either arising
from neuropathic, neurovascular or musculoskeletal
disorders.  He described symptoms associated with
each of these systems by their location, duration,
frequency, quality of pain, precipitating factors and
ameliorating factors.
Ninety per cent of orofacial pain arises from the
teeth and oral structures13.  As dentists, we are trained
to diagnose and treat often acute dental pain problems.
After ruling out dental problems, musculoskeletal and
neuropathic pain conditions are the most common
causes of facial pain. Due to the diversity of
manifestations and different mechanisms of pain
transmission, the differential diagnosis is crucial for
the establishment of a successful management strategy.
Based on that, the aim of this paper is to review
basic concepts of pain transmission of the trigeminal
system as well as to discuss differences between
musculoskeletal and neuropathic pain.
PAIN TRANSMISSION IN THE
TRIGEMINAL SYSTEM
Pain sensation from the intraoral and extraoral
structures of the head and face are carried to the Central
Nervous System (CNS) by the trigeminal system1,13.
Rather than a single nerve pathway, the term
“trigeminal system” refers to a complex arrangement
of nerve transmission fibers, interneurons, and synaptic
connections which process incoming information from
the three divisions of the trigeminal nerve. The
trigeminal nerve is a mixed nerve containing both
sensory and motor fibers.  Sensory fibers innervate
the anterior part of the face, teeth, mucous membranes
of the oral and nasal cavities, conjunctiva, dura mater
of the brain, and intracranial and extracranial blood
vessels. Motor fibers supply the muscles of
mastication. Sensory information from the face and
mouth (except proprioception) is carried by primary
afferent neurons through the trigeminal ganglion to
synapse with second order neurons in the trigeminal
brain stem complex (Figure 1).  While this complex
receives afferent input primarily from the trigeminal
nerve, it also receives afferent axons from the facial,
glossopharyngeal, vagus, and the upper cervical (C2,
C-3) nerves. (This connection between the upper
cervical nerves and the trigeminal spinal tract nucleus
may be a mechanism involved in facial pain and
headaches.)
The trigeminal-brain stem sensory nuclear complex
can be separated into the trigeminal main sensory
nucleus and the trigeminal spinal tract nucleus, also
known as the nucleus of the descending tract of cranial
nerve V6.
The spinal tract nucleus is composed of three
separate nuclei proceeding in a rostral (superior) to
caudal (inferior) direction: subnucleus oralis,
subnucleus interpolaris, and subnucleus caudalis.
Subnucleus caudalis, the most caudal, is located in
the medulla, at times extending to the level of C2 or
C3 and is the principal brain relay site of nociceptive
information arising from the orofacial region. Because
the nucleus caudalis is continuous with, and
structurally similar to, the spinal cord dorsal horn, and
because it also extends into the medulla, it is often
referred to as the medullary dorsal horn12.  Both
incoming nociceptive signals to the subnucleus
caudalis and projecting nociceptive signals on their
way to the thalamus can be modified (modulated) by
descending nerve fibers from higher levels of the CNS
or by drugs.
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FIGURE 1 - Mechanism of Pain transmission in the
trigeminal system ( Adapted with permission of Dr. J.
Harding, Univ. of  Wisconsin)
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Convergence of Neurons within the Trigeminal
Spinal Tract
Nerve fibers from different areas in the mouth may
all synapse on another neuron in the spinal cord, thus
sending a signal to the brain. In many cases, the brain
is unable to interpret the exact location of the original
oral stimulus17. A common example of this in dental
practice is early pulpal pain.  Pulpal tissue can be
classified as “visceral tissue”, in a manner similar to
kidney tissue.  In an inflammatory or pain process, a
signal is sent only when a certain critical level of insult
is reached, e.g. deep caries or an early pulpitis.  This
brain may appreciate that there is a toothache
somewhere but cannot localize it, and, due to
convergence factors, the brain may experience more
difficulty in localizing the pain.  Every day in general
practice we hear patients say “Doc, I have a toothache
but I don’t know where it is”.
Trigeminal Second Order Neurons
Trigeminal second order nociceptive neurons in the
subnucleus caudalis can be classified into two main
groups; nociceptive specific (NS) neurons and wide
dynamic range (WDR) neurons. NS neurons respond
exclusively to noxious stimuli such as heat and pinch.
Their receptive fields are small and may include skin
and muscle.  WDR neurons are excited by both
noxious stimuli and non-noxious tactile stimuli over
a wide range of intensities. The receptive fields of
WDR neurons are considerably larger than the
receptive fields of NS neurons. In addition, nucleus
caudalis contains low-threshold mechanoreceptors
(LTM) which are activated by light tactile stimuli.
These neurons have axons which form an ascending
tract conducting nociceptive signals to higher levels
of the brain for further processing.
Third Order Neurons
The next major synaptic connection in pain
transmission is in the thalamus where axons traveling
in the trigeminothalamic tract synapse with third order
neurons.  All sensory information from the spinal cord
and brainstem passes through the thalamus making it
one of the primary relay stations between the brainstem
and different parts of the somatosensory cerebral
cortex. For all nerve pathways from the thalamus to
the cerebral cortex, there are reciprocal connections
from the cortex to the thalamus. Sensory information
reaching the thalamus may also be relayed to several
distinct nuclei in the thalamus.
At the thalamic level, the action potential will be
subjected to extensive processing through interactions
among its various nuclei and by interconnections with
the limbic, hypothalamic and cortical regions of the
brain. It should be appreciated that until the nociceptive
signal reaches the level of the thalamus, most of the
reactions in the CNS have been reflex in nature. Only
when the thalamus is involved, are the elements of
consciousness and alertness introduced.
Pain Modulation
The human nervous system has an inherent ability
to alter the intensity of nociceptive signals and reduce
the pain experience.  This process is called modulation.
The key pathway starts in a section of the brain called
the periqueductal gray region in the midbrain.  Signals
from this area of the brain descend to the spinal cord
dorsal horn where further neuron interaction serves
to reduce the transmission of the primary pain signal
from the peripheral nociceptor to the second order
neuron. This modulation also takes place within the
spinal trigeminal nucleus.
Pain Perception
After transmission and modulation of the
nociceptive signals, the final process is the perception
of pain, which takes place in the posterior parietal
cortex of the brain.  The homunculus is a distorted
human figure drawn to reflect the space our body parts
occupy on the sensory cortex. The picture looks like a
misshapen “little man” whose swollen lips, hands, oral
cavity reflect the disproportionately large cortical areas
they occupy.  The differences in the size of the sensory
map on the brain may reflect differences in functional
importance.  Thus one can see the relative importance
of the oral cavity as the entrance to the digestive tract,
possibly as protection.
MUSCULOSKELETAL PAIN
Musculoskeletal pain is deep, constant, dull and
typically associated with a sense of tightness or
pressure. It can be occasionally sharp and is increased
by functional activity of the involved structures.
Musculoskeletal pain can have a depressing effect in
that it causes the patient to withdraw from various
activities in which he or she might normally be able
to participate17
One of the most important features of
musculoskeletal pain is that it is provocable and true
03
 2003; 11(1): 1-7
to provocation. An excellent agreement has been
documented for detection of TMD of muscular origin
by means of palpation after a training and calibration
program3. An injured joint or muscle may be sore,
painful when at rest, or it may be tender. Tenderness
is pain with movement or provocation. Simply stated,
an injured joint or muscle may be painful, but the pain
will always increase with function of the injured
structure. Just as a sprained ankle should hurt when
walked on, an injured or inflamed temporomandibular
joint should become more painful with mandibular
movement. Therefore, one of the most important
questions asked of a potential temporomandibular
disorder patient is, “Does it hurt to chew?” In addition
to provocability, musculoskeletal pain is also graded.
The more the injured joint or muscle is moved or
loaded, the greater the pain or discomfort.
The most common form of musculoskeletal pain
affecting the head, neck and face is myofascial pain9,11,
which is a regional pain disorder. The main
characteristic of myofascial pain is the formation of
myofascial trigger points (TPs). These are localized
area of tender nodules in tight, palpable bands of
muscle. Muscles affected by active myofascial trigger
points have a reduced active range of motion. More
important, when provoked, myofascial trigger points
cause the referral of pain in reproducible patterns
remote from the site of the trigger point. Pain
intensifies with palpation of the trigger point. The area
to which pain is referred is known as the zone of
reference and is often distant from the involved muscle.
Referred pain is not necessarily in the same
dermatome. Despite this, the pattern of pain referral
is reproducible, consistent and serves as a guide to
locate the primary source of pain17.
A jump sign occurs with firm palpation of a trigger.
This form of palpation can result in a spontaneous
reaction, which includes a verbal response or report
of pain from the patient and a reflexive withdrawal of
the patient’s head. A twitch response is the rapid,
contractile motor effect elicited by “snapping
palpation” of a taut band at the location of the trigger
point.
The clinical implications of this knowledge are to
provide the orofacial pain dental specialist with the
tools to best detect the source of pain.  Musculoskeletal
pain, this deep, dull, aching and provocable pain is
not always perceived at its source. More frequent than
not, the source of the pain and the site where pain is
felt are not the same. Knowledge of how to palpate
for a myofascial trigger points and cause it to reproduce
and refer pain is of great importance in establishing a
diagnosis. Of equal importance is a recognition of the
referral patterns; the zones of reference. When a patient
presents with deep, dull and aching pain, know the
source of the active trigger point most likely to refer
to the distribution of pain also helps to go to the point
of pain directly.
Treatment is more successful with a clear diagnosis.
Treatment
The approach to treatment of musculoskeletal pain
should address the specific symptoms and clinical
findings in each case. Several therapies, including
analgesics, antiinflammatory and adjuvant
medications, physical therapy and anesthetic block
have been proposed for the treatment of myofascial
pain.
The use of analgesic and anti-inflammatory
medications is the first therapeutic step. They are
efficient for acute pain control and may aid with
physical therapy; however, chronic use is not indicated.
Peripheral muscle relaxants are less effective then
are central agents.  Centrally acting muscle relaxants
with good efficacy are cyclobenzaprine and tizanadine.
Tricyclic antidepressants such as amitriptyline,
chlorimipramine and nortriptyline act as serotonin
reuptake inhibitors and aid with pain modulation and
sleep patterns20.
Benzodiazepines such as alprazolam, cloxazolam
and clonazepam are effective when taken with non
steroidal antiinflammatory drugs (NSAIDs) for
treating acute muscle pain.
The goal of physical therapy is the inactivation of
myofascial trigger points, muscles relaxation, muscle
rehabilitation, and postural education. In addition,
identification, assessment and elimination of
contributing and perpetuating factors are vital21.
There are several effective physical therapy
techniques useful in treating muscle dysfunction and
pain. They include superficial heat (warm-wet), deep
heat (ultrasound), cryotherapy (ice pack, vapocoolant
spray) and electrotherapy (electrical stimulation
(TENS). These modalities reduce muscle tension,
decrease inflammation and inactivate myofascial
trigger points. In complex and chronic cases, physical
therapy alone may not be satisfactory, or when physical
therapy is not effective or the intensity of the pain is
too high, trigger point injections may be necessary.
Done with either a dry needle technique or by
infiltration with local anesthetic, myofascial trigger
point injections can reduce pain, improve the
mandibular range of motion, improve the tolerance to
exercise and improve the microcirculation at the
affected area. Pain relief can last from as little as
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several hours or for several months20.
The medication of choice for myofascial trigger
point injection therapy is lidocaine 0.5% to 1% without
vasoconstrictors. After the injection, the muscle should
be progressive stretched to reestablish a normal
mandibular motion. In addition, some success has been
reported in treating myofascial pain with intramuscular
Botox injections7. This technique promises to be of
some use in the future, but does not yet have clear
scientific support.
Myofascial trigger points inactivation by itself
provides temporary decrease of symptoms.
Rehabilitation exercises decrease the possibility of
reactivation of the TPs. The goal of muscle reeducation
is to control aggravating and perpetuating factors.
Therefore, long-term therapy includes not only the
treatment of the myofascial trigger points, but also
the identification and elimination of contributing and
perpetuating factors21.
An accurate evaluation to assess if symptoms are
independent or secondary manifestation of a systemic
disease is mandatory. Patients with systemic diseases
such as fibromyalgia or rheumatologic disorders are
more likely to present with pain or to maintain pain as
a result of these perpetuating factors16.
The institution of good habits such as a balanced
diet, restorative sleep, regular physical activities,
relaxation and decrease of psychological and physical
stress factors is vital to the prevention of a reoccurrence
of symptoms. The psychosomatic approach includes
relaxation techniques such as biofeedback, supportive
psychotherapy and pharmacotherapeutics when
indicated for anxiety or depression.
The treatment of musculoskeletal pain can be
difficult in chronic cases. However, an accurate
diagnosis, elimination of contributing factors,
necessary pharmacotherapeutics, physical therapy and
patient compliance can lead to successful management.
Conti et al4 have demonstrated a decrease of about
50% in pain severity of chronic TMD patients, in spite
of the type of pain measurement or type of treatment.
NEUROPATHIC PAIN
Neuropathic pain is one of the most challenging
and complex pain conditions. It results from an
abnormality in one or more components of the nervous
system: peripheral, central or autonomic. These
disorders comprise a group of subtypes precipitated
by neural injury or disease that can result in a
neuropathic pain problem, abnormal sensation or a
sensory deficit. Neuropathic pain does not require the
presence of a noxious stimulus in contrast to somatic
pain, which does. As stated above, a noxious stimulus
(excessive heat, cold and pressure, chemical) either
causes tissue damage or has the potential to do so.
These pain manifestations are usually maintained
by changes in the trigeminal brain stem complex
known as central neuroplasticity2. When central
neuroplasticity is prolonged, the result is a state of
chronic or pathophysiologic pain. Because
pathophysiologic pain always involves the nervous
system, the terms pathophysiologic pain and
neuropathic pain are used interchangeably.
An important effect of central neuroplasticity is
hyperexcitability of second-order neurons in the
trigeminal brain stem known as central sensitization14.
Clinical consequences of central sensitization include
pain in response to a non-noxious stimulus (allodynia),
increased pain to a noxious stimulus (hyperalgesia)
and spreading of the pain. Other peripheral neural
mechanisms such as neurogenic inflammation can also
contribute to pathophysiologic pain13,14. It is believed
that ongoing, sustained nociceptive activity may lead
to central neuroplasticity.
General characteristics of neuropathic pain include:
1. Pain in the absence of obvious nociception (i.e.,
detection of noxious stimuli);
2. Pain that can be intense and out of proportion to
the degree of stimulation;
3. Pain quality that is bright, stimulating and
burning;
4. Pain that is relatively unresponsive to low doses
of narcotic analgesics.
Neuropathic pain is divided into episodic and
continuous disorders. The episodic disorders are
characterized by periods of total remission between
episodes of paroxysmal pain. In contrast, the
continuous neuropathic disorders have constant
unremitting pain of varying levels of intensity without
any periods of total remission. The most common
episodic neuralgia affecting the orofacial region is
trigeminal neuralgia; atypical odontalgia (AO) is a
prime example of a continuous neuropathic pain
disorder.
A history of a toothache refractory to any nature
of treatment is the common complaint of the atypical
odontalgia patient. Unfortunately, information about
the existence of  these conditions is very reduced
among general practitioners and more and more
invasive procedures ( endodontic treatment, surgeries)
has still been recommended to alleviate the pain.
It is crucial, therefore, to understand the process
involved in AO and elect the better management other
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than traditional dental pain therapy.
The most likely mechanism involved in AO is
related to deafferentation following injury to a nerve.
In fact, several clinicians now prefer to use the term
trigeminal deafferentation pain instead of atypical
odontalgia.
Deafferentation is the partial or total loss of an
afferent nerve supply from a particular area13,19. Trauma
to a nerve commonly follows dental procedures
involving the dentin, pulp or periodontal tissues. In most
patients, the nerve damage is reversible within a short
time. However, in a small percentage of patients (less
than 3%) who have undergone a dental procedure, pain
will persist even after healing has apparently occurred.
Interestingly, the pain may not appear for weeks, months
or even a year after the procedure. Why pain occurs in
some patients after deafferentation is not known. It has
been hypothesized that perhaps there is a genetic
predisposition in these patients8,10.
Involvement of the sympathetic nervous system
(SMP) in AO has also been suggested, based on the
reported improvement in symptoms in some patients
following a stellate ganglion block8. However, more
studies are needed to show the role of SMP in AO.
The management of AO is extremely difficult and
no single approach has proven to be universally
effective. AO is a chronic disorder that perplexes and
frustrates both the patient and the clinician. Once AO
has been diagnosed, the earlier the intervention, the
better the prognosis. Of course, any dental treatment
such as endodontic treatment, apicoectomy, extraction
and selective tooth grinding is contraindicated. The most
widely used approaches for treatment of AO are
pharmacotherapy (tricyclic antidepressants15 and
membrane stabilizers) and topical applications (
capsaicin). If sympathetic involvement is suspected,
clonidine, an alpha-2- adrenergic agonist, can be added
to the formulation. This drug acts to decrease the release
of norepinephrine from presynaptic sympathetic
terminals.
As could be seen, different mechanisms can produce
similar clinical expressions. This fact strengtens the
need for a differential diagnosis based on the knowledge
of concepts of pain transmission. The concept of
“Evidence Based Dentistry” must always guide clinical
procedures, especially in a field where invasive and
irreversible procedures with poor scientific evidence
historically comprised standard management strategies.
In other words, when performing treatments like
occlusal therapies and full mouth rehabilitation, skillful
professionals might be doing the “thing right”, but, since
pain management is the main issue, they are not doing
the “right thing”.
RESUMO
Dor Orofacial é um campo da odontologia dedicado
ao diagnóstico e tratamento de dores orofaciais
crônicas e complexas, além d e desordens motoras.
Essa especialidade odontológica tem se desenvolvido
por vários anos com o objetivo de prover um melhor
entendimento de um grupo de pacientes que, de alguma
forma, não tinham dores de origem dentária e nem
condições óbvias médicas que explicassem suas dores
na face. Depois de um longo período propondo
tratamentos baseados apenas no aspecto mecanicista
da doença, nossa profissão percebeu a importância de
entender mecanismos básicos de diagnóstico
diferencial para melhor controlar esses casos. Essa
mudança de mentalidade tem levado a modificações
na educação em odontologia, assim como nos
procedimentos clínicos executados. Historicamente
considerada como um “problema de oclusão”, as dores
orofaciais obtiveram recentemente o reconhecimento
como especialidade em nosso país. Baseado nisso, o
objetivo desse artigo é discutir diferenças básicas entre
os tipos mais comuns de dor orofacial, assim como
ressaltar a importância do conhecimento de
mecanismos de condução de dor para a formulação
de um plano de tratamento efetivo.
UNITERMOS: Dor orofacial; Dor muscular;
Neuropatia.
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